Area of research
Oncology · Molecular Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Viral-associated cancers and disorders, and Viral gastroenteritis research and epidemiology.
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer
Primary mucosal melanomas of the head and neck are characterised by overexpression of the <scp>DNA</scp> mutating enzyme <scp>APOBEC3B</scp>
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers
Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits
The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase
HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulators
Polyomavirus T Antigen Induces <i>APOBEC3B</i> Expression Using an LXCXE-Dependent and TP53-Independent Mechanism
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1
Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
Mutation Signatures Including APOBEC in Cancer Cell Lines